Selventa

BiotechnologySeries ACambridge, USselventa.com

Latest round

Series A

Last raised

Nov 2011

Total raised

$11M

Investors

3

About Selventa

Selventa analyzes molecular patient data, accelerates the development process and clarifies decisions on therapeutics and diagnostics for pharmaceutical and biotechnology partners.

Who invested in Selventa

3 investors across 2 rounds

See all investors in Selventa

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 28, 2011

    Amount

    $5M

    Investors

    Locked

  2. Series A

    Sep 8, 2003

    Amount

    $6.5M

    Investors

    Locked

Questions about Selventa

Who invested in Selventa?

Selventa has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Selventa raised?

Selventa has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Selventa last raise money?

Selventa's most recent round on record is a Series A, in Nov 2011.

What does Selventa do?

Selventa analyzes molecular patient data, accelerates the development process and clarifies decisions on therapeutics and diagnostics for pharmaceutical and biotechnology partners.

Where is Selventa headquartered?

Selventa is headquartered in Cambridge, US.

Which VCs invest in companies like Selventa?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Selventa's stage. Their profiles are linked below.

Raising like Selventa? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.